Panagora Asset Management Inc Soleno Therapeutics Inc Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.5 - $2.99 $8,167 - $16,280	-5,445 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$1.93 - $2.95 $14,905 - $22,782	-7,723 Reduced 58.65%	5,445 $15,000
Q1 2019 May 15, 2019	SELL	$1.35 - $2.68 $7,373 - $14,638	-5,462 Reduced 29.32%	13,168 $27,000
Q4 2018 Feb 14, 2019	BUY	$1.55 - $2.3 $10,507 - $15,591	6,779 Added 57.2%	18,630 $32,000
Q3 2018 Nov 13, 2018	BUY	$1.95 - $3.07 $14,034 - $22,094	7,197 Added 154.64%	11,851 $26,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $3.1 $7,260 - $14,427	4,654 New	4,654 $11,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.